Navigation Links
diaDexus, Inc. Highlights Findings from Two Outcomes Studies for its PLAC Lp-PLA(2) Activity Assay
Date:3/19/2012

ocused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease. The company's PLAC® Test ELISA kit is the only blood test cleared by the FDA to aid in predicting risk for both CHD and ischemic stroke associated with atherosclerosis, the #1 and #3 causes of death, respectively, in the United States. For more information, please visit the company's website at www.diaDexus.com. The company's PLAC Test for Lp-PLA(2) Activity has received CE marking in the European Union to aid in predicting risk for CHD.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about the company's plans, objectives, expectations and intentions with respect to future financial results, operations and products and other statements that are not historical in nature, particularly those that use terminology such as "will," "potential", "could," "can," "believe," "intends," "continue," "plans," "expects," "estimates" or comparable terminology. Forward-looking statements are based on current expectations and assumptions, and entail various known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed in such forward-looking statements. Important factors known to diaDexus that could cause actual results to differ materially from those expressed in such forward-looking statements include diaDexus' ability to submit a new 510(k) application for, and obtain FDA clearance of, its new automated Lp-PLA(2) Activity test; diaDexus' ability to gain acceptance of its PLAC® Test products in the marketplace, including its ability to demonstrate that treatment of individuals based on their Lp-PLA(2) levels improves clinical outcomes in prospective
'/>"/>

SOURCE diaDexus, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. diaDexus, Inc. Reports 2011 Fourth Quarter and Year-End Financial Results
2. diaDexus, Inc. to Host Webcast March 15, 2012 on 2011 Fourth Quarter and Year-End Financial Results
3. diaDexus, Inc. Reports 38% Year-Over-Year Revenue Growth for 2011 Third Quarter
4. diaDexus, Inc. Reports 2011 First Quarter Financial Results
5. diaDexus, Inc. Reports 2010 Third Quarter Financial Results
6. diaDexus, Inc. Adds Two New Directors; Corporate Overview & 3Q Results Webcast Set for November 16, 2010
7. Elekta Highlights Latest Version of MOSAIQ Oncology Information System at HIMSS12 Meeting
8. Bionovo to Host Conference Call to Discuss 2011 Highlights and Year-End Financial Results
9. UBM Medicas Musculoskeletal Network Highlights Key Orthopedic Findings From AAOS
10. Zacks Voice of the People highlights opportunities with Walgreen, Occidental Petroleum and Brown & Brown
11. Ampio Pharmaceuticals Reports Full-Year 2011 Financial Results and Milestone Highlights for 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... YORK , Sept. 16, 2014 The ... Foundation (HNF) announced today an agreement to collaborate on ... and support the development of a stronger CMT patient ... financial support to several HNF,s initiatives including: ... in the HNF website featuring  HNF newsletters, materials and ...
(Date:9/15/2014)... , Sept. 16, 2014  Bayer HealthCare and ... Finland , have begun to ... ODM-201, an investigational oral androgen receptor inhibitor in ... in men with castration-resistant prostate cancer who have ... detectable metastases. The trial is designed to determine ...
(Date:9/15/2014)... , Sept. 15, 2014 /CNW/ - Health Minister Rona ... will make available for donation over $2.5 million in personal ... aid in the global response to the Ebola outbreak in ... WHO reported a shortage of equipment in the affected countries ... by front-line workers in the affected countries. ...
Breaking Medicine Technology:Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 2Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 3Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 4Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer 2Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer 3Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 2Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 3
... 28 Having hypertension, or high blood,pressure, reduces blood ... to a new study presented today at the annual ... "While hypertension is not a cause of Alzheimer,s disease, ... brain that increases its vulnerability,to the effects of the ...
... to ... total knee replacement, MINNEAPOLIS, ... of OrthoGlide Medial Knee Implant initial,clinical data., Data representing ... was presented on November 10th, 2007 at the,American College of ...
Cached Medicine Technology:High Blood Pressure May Heighten Effects of Alzheimer's Disease 2Clinical Data Presented on OrthoGlide(R) Medial Knee Implant 2
(Date:9/16/2014)... San Diego, CA (PRWEB) September 16, 2014 ... a new hydrating lip gloss that true-ly pampers lips from ... your lips satin-smooth all day. , “The creation of true ... were suffering from dry, dehydrated lips no matter what products ... that not only looked great on, but could actually hydrate ...
(Date:9/16/2014)... DiaperBuys, a national online retailer of ... this September. Healthy Aging Month was started more than ... on the positive aspects of growing older. , ... side effects from medications that cause urinary incontinence,” explains ... DiaperBuys.com. “This can seem daunting to some patients, especially ...
(Date:9/16/2014)... September 16, 2014 Today, the Diamond ... Icon Awards to be held, Sunday, October 19, 2014 ... The annual awards show honors the dare-devil stuntwomen ... extreme sports stars. Over 12 categories will be ... ESPN’s Kenny Mayne. , Special honors will be ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 ... monthly specials this month, kicking off September with ... spa in Clearwater, FL chose to highlight lumablanc® ... immediate activation upon contact with the skin. , ... of their best-selling lumafirm® anti-aging line. The brightening ...
(Date:9/16/2014)... 2014 Banish headaches forever with the ... Cefaly device for chronic migraine relief and treatment. Cefaly ... United States. Until now, US patients would directly place ... Belgium and wait 2-3 weeks for their device to ... States and once prescription and payment is received, the ...
Breaking Medicine News(10 mins):Health News:True Science Cosmetics, LLC Launches True Lipz™ 2Health News:DiaperBuys Honors ‘Healthy Aging’ Month throughout September 2Health News:DiaperBuys Honors ‘Healthy Aging’ Month throughout September 3Health News:Hollywood's Action Icon Awards to Honor Legendary Stuntwomen In A Star-Studded Gala and Awards Ceremony 2Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 2Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 3Health News:Cefaly Migraine Treatment Device Now Readily Available For Widespread Purchase in United States 2
... colonised by E. coli bacteria early in life have ... a study of infants carried out at the Sahlgrenska Academy at ... outnumber the cells in our bodies by a factor of ten ... maturation of the immune system. The normal bacterial flora in the ...
... 2012) Autism Speaks is pleased to announce the launch ... in Toddlers, or M-CHAT. The M-CHAT is a scientifically validated ... age to assess their risk for autism spectrum disorder (ASD). ... Fein, Ph.D. and clinical psychologist Marianne Barton, Ph.D. The American ...
... Scientists who found a way to make white fat behave ... new obesity treatments. Brown fat burns energy (preventing obesity), ... cells are associated with fat accumulation around organs in the ... an increased risk for diabetes and heart disease, the researchers ...
... participation in a brief training program designed to ... in how patients perceived their interactions with the ... empathy with patients usually drops during medical school ... of Massachusetts General Hospital (MGH) researchers will appear ...
... against serious pneumococcal disease does not offer full protection, ... of Gothenburg, Sweden, finding that the number of cases ... Each year an estimated 1 million children worldwide die ... those in poor countries, but pneumococcal bacteria cause disease ...
... 6, 2012) - Eye color may be an indicator of ... A study, led by the University of Colorado School of ... have vitiligo. It then follows, according to scientists, that people ... Vitiligo is an autoimmune skin disease in which pigment loss ...
Cached Medicine News:Health News:Gut flora affects maturation of B cells in infants 2Health News:Automated autism screening tool available on Autism Speaks website 2Health News:Brief training program improves resident physicians' empathy with patients 2Health News:Brief training program improves resident physicians' empathy with patients 3Health News:Pneumococcal disease: More cases but fewer deaths 2Health News:Eye color may indicate risk for serious skin conditions 2
For the quantitative determination of Iron and IBC in serum. Colorimetric method utilizing ferrozine. Endpoint procedure measured at 560 nm. Linearity: 500 ug/dl....
HDL Cholesterol (PEG) Precip. Reagent + 5 ml of 50 mg/dl cholesterol std....
Intended for the quantitative in vitro enzymatic determination of JDL-Cholesterol in human serum or plasma. Two point reaction. Wavelength: 600 nm. Linearity: 1 to 150 mg/dL (0.03 mmol/L to 3.89 mmol...
... Intended for the quantitative ... plasma. Two vials, dry ... alphaketoglutarate. Uses NADPH to ... plasma compounds. Reaction: Enzymatic, ...
Medicine Products: